Sethuraman Natarajan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
19
Insider Sells Sum
$1.51M

Insider Activity of Sethuraman Natarajan

According to the SEC Form 4 filings, Sethuraman Natarajan, being in a position of

  1. President, Research & Develop. at Entrada Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25907 shares for $398,810,
    over all time since 2023-04-17, has bought 0 shares, and sold 110025 shares for $1.9M.

Biography of Sethuraman Natarajan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $398,8101100

Comparison of Insiders on Amount of Buys and Sells

2026-05-04SaleEntrada Therapeutics, Inc.
TRDA
President, Research & Develop.
25,907
0.0708%
$15.39$398,810-56.93%
2024-12-03SaleEntrada Therapeutics, Inc.
TRDA
President, Research & Develop.
11,703
0.0312%
$20.15$235,786-60.29%
2024-12-02SaleEntrada Therapeutics, Inc.
TRDA
President, Research & Develop.
4,088
0.0108%
$20.26$82,834-60.58%
2024-11-29SaleEntrada Therapeutics, Inc.
TRDA
President, Research & Develop.
100
0.0003%
$20.00$2,000-59.73%
2024-11-13SaleEntrada Therapeutics, Inc.
TRDA
President, Research & Develop.
2,700
0.0072%
$20.04$54,109-59.87%
2024-11-11SaleEntrada Therapeutics, Inc.
TRDA
President, Research & Develop.
1,409
0.0038%
$20.01$28,191-59.7%
2024-11-06SaleEntrada Therapeutics, Inc.
TRDA
President, Research & Develop.
12,299
0.0336%
$18.85$231,776-56.51%
2024-11-05SaleEntrada Therapeutics, Inc.
TRDA
President, Research & Develop.
5,171
0.0142%
$18.18$94,006-56.39%
2024-11-04SaleEntrada Therapeutics, Inc.
TRDA
President, Research & Develop.
749
0.002%
$18.02$13,498-54.28%
2024-10-16SaleEntrada Therapeutics, Inc.
TRDA
President, Research & Develop.
600
0.0018%
$18.00$10,800-50.71%
2024-09-09SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
2,642
0.0071%
$15.09$39,862-28.24%
2024-09-06SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
600
0.0017%
$15.24$9,141-26.96%
2024-07-15SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
638
0.0024%
$18.00$11,484-23.82%
2024-07-12SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
600
0.0023%
$18.00$10,800-19.48%
2024-05-20SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
9,675
0.0284%
$15.19$146,944-0.91%
2024-05-17SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
8,305
0.0253%
$15.14$125,751+2.07%
2024-05-16SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
1,000
0.003%
$15.00$15,000+2.04%
2023-07-11SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
14,852
0.0459%
$18.04$267,915-18.18%
2023-07-10SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
3,026
0.0094%
$18.00$54,474-18.05%
2023-04-17SaleEntrada Therapeutics, Inc.
TRDA
Chief Scientific Officer
3,961
0.0122%
$18.00$71,316-18.85%
Total: 20
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.